Many Ugandans continue to face delayed diagnoses, limited access to specialised care, and low public awareness about eye ...

Objectives: This study aimed to evaluate the effectiveness of deep learning model in assisting dermatologists in classifying basal cell carcinoma (BCC) from seborrheic keratosis (SK). The goal was to ...

This paper investigates how isoform II of transcription factor RUNX2 promotes cell survival and proliferation in oral squamous cell carcinoma cell lines. The authors used gain and loss of function ...

is a rare cancer with periocular predilection. Studies focused on patterns and timing of nodal metastasis are scarce. Our aim is to report patterns of regional nodal metastasis in patients with eyelid ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using ...

The unnamed 4-year-old Henkel’s leaf-tailed gecko had developed lumps on its neck that turned out to be squamous cell carcinoma, a potentially deadly form of skin cancer, according to the Zoo’s ...

Several components of the hedgehog (Hh) pathway are crucial to basal cell carcinoma (BCC) tumorigenesis. Primary cilia have emerged as key organelles in Hh signal transduction in mammalian systems ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

A new discovery could pave the way for more effective cancer treatment by helping certain ... to improve their ability to slip through cell membranes by passive diffusion. But the new strategy ...

researchers delivered 7.7 to 22.3 times more of the drug inside cancer cells, making the treatment up to 23 times more potent than before, according to the study published April 17 in Cell.

they were able to deliver between 7.7 and 22.3 times more of the drug into cancer cells – making the treatment up to 23 times more effective, according to a study published today (April 17) in Cell.